Amerisource Faces Government Source: CEO Disputes Report Of Inquiry
Executive Summary
An investigation of AmerisourceBergen's role in facilitating drug diversion appears to focus on an institutional pharmacy that Amerisource dropped as a client in 2000, CEO David Yost said